Reshma Rangwala insider trades: Karyopharm Therapeutics (KPTI) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Reshma reports to the SEC
Open-market buys and sales
9 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 14, 2026 | KPTI | ↓ Sell | 408 | $9.50 | $4K | Direct | May 15, 2026 (1d) |
| Apr 21, 2026 | KPTI | ↓ Sell | 449 | $8.94 | $4K | Direct | Apr 22, 2026 (1d) |
| Mar 2, 2026 | KPTI | ↓ Sell | 5,066 | $9.41 | $48K | Direct | Mar 3, 2026 (1d) |
| Sep 15, 2025 | KPTI | ↓ Sell | 408 | $6.43 | $3K | Direct | Sep 16, 2025 (1d) |
| Apr 23, 2025 | KPTI | ↓ Sell | 419 | $6.17 | $3K | Direct | Apr 24, 2025 (1d) |
| Mar 4, 2025 | KPTI | ↓ Sell | 3,587 | $6.29 | $23K | Direct | Mar 6, 2025 (2d) |
| Apr 22, 2024 | KPTI | ↓ Sell | 6,789 | $1.17 | $8K | Direct | Apr 23, 2024 (1d) |
| Mar 1, 2024 | KPTI | ↓ Sell | 21,636 | $1.18 | $25K | Direct | Mar 4, 2024 (3d) |
| Apr 20, 2023 | KPTI | ↓ Sell | 6,770 | $4.05 | $27K | Direct | Apr 24, 2023 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other KPTI insiders
Open-market trades in the last 12 months
About Reshma Rangwala's insider trades
Reshma Rangwala is EVP & Chief Medical Officer at Karyopharm Therapeutics (KPTI). Since Apr 20, 2023, Reshma has reported no open-market purchases and 9 sales worth $144K on SEC Form 4. In the last 12 months: 3 sales ($56K).
Their filings also include grants and awards (11 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KPTI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.